Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre.

Twelves, Chris; Cheeseman, Sue; Sopwith, Will; Thompson, Matthew; Riaz, Majid; Ahat-Donker, Necibe; Myland, Melissa; Lee, Adam; Przybysz, Raymond; Turner, Stuart; Hall, Geoff; Perren, Tim

Twelves, Chris; Cheeseman, Sue; Sopwith, Will; Thompson, Matthew; Riaz, Majid; Ahat-Donker, Necibe; Myland, Melissa; Lee, Adam; Przybysz, Raymond; Turner, Stuart; Hall, Geoff; Perren, Tim.

Afiliação

Twelves C; Clinical Cancer Pharmacology and Oncology, Leeds Cancer Centre, St James's University Hospital, Level 4, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK. c.j.twelves@leeds.ac.uk.
Cheeseman S; University of Leeds, Leeds, UK. c.j.twelves@leeds.ac.uk.
Sopwith W; Clinical Cancer Pharmacology and Oncology, Leeds Cancer Centre, St James's University Hospital, Level 4, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK.
Thompson M; Clinical Cancer Pharmacology and Oncology, Leeds Cancer Centre, St James's University Hospital, Level 4, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK.
Riaz M; IQVIA, London, UK.
Ahat-Donker N; Clinical Cancer Pharmacology and Oncology, Leeds Cancer Centre, St James's University Hospital, Level 4, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK.
Myland M; Clinical Cancer Pharmacology and Oncology, Leeds Cancer Centre, St James's University Hospital, Level 4, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK.
Lee A; Clinical Cancer Pharmacology and Oncology, Leeds Cancer Centre, St James's University Hospital, Level 4, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK.
Przybysz R; IQVIA, London, UK.
Turner S; IQVIA, London, UK.
Hall G; Novartis Pharmaceuticals UK Ltd, Surrey, UK.
Perren T; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

BMC Cancer ; 20(1): 53, 2020 Jan 21.

Article em En | MEDLINE | ID: mdl-31964373

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Receptor alfa de Estrogênio/metabolismo; Receptor ErbB-2/metabolismo; Receptores de Progesterona/metabolismo; Adulto; Idoso; Idoso de 80 Anos ou mais; Neoplasias da Mama/epidemiologia; Neoplasias da Mama/patologia; Inglaterra/epidemiologia; Feminino; Humanos; Estudos Longitudinais; Pessoa de Meia-Idade; Metástase Neoplásica; Estudos Retrospectivos; Taxa de Sobrevida; Resultado do Tratamento

Palavras-chave

Chemotherapy; Endocrine therapy; HR+/HER2-; Metastatic breast cancer; Overall survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptor ErbB-2 / Receptor alfa de Estrogênio Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google